Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat
about
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequenceHIV-1 Tat protein mimicry of chemokinesA novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectinTat protein induces self-perpetuating permissivity for productive HIV-1 infectionExtracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytesHigher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variantsRetroviruses and cancer: models for cancer in animals and humans.Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.Human immunodeficiency virus Tat associates with a specific set of cellular RNAsComplete genome sequence of a Megalocytivirus (family Iridoviridae) associated with turbot mortality in ChinaIntegrins.Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.Tat-neutralizing antibodies in vaccinated macaques.HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.Molecular characterization of full-length Tat in HIV-1 subtypes B and CMorphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathEpitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissueEndocytosis and targeting of exogenous HIV-1 Tat protein.Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitopeHIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes.Selenoprotein T deficiency alters cell adhesion and elevates selenoprotein W expression in murine fibroblast cells.Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.Genetic regulation of human immunodeficiency virus.Tits and bits of HIV Tat protein.The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism.Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequenceTGF beta and HIV infection.Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression.HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers.
P2860
Q24561727-ABB117C1-D81F-45FE-A272-2C42C38603CEQ24644383-DEEEFDEF-EE36-4B62-85EA-4977964D5A21Q24651246-EFE06152-7C28-46E6-836F-992D0A5F2E9EQ24683211-99B5D5B8-BABD-4F80-A905-9E9355CF4203Q24683736-3D0940C9-D88B-44A6-A1D3-7621B58A353FQ25256833-48C8C0AE-4551-4892-BF41-E72EBF5CE1FDQ30467457-57602E6E-A1DE-4098-87F3-597A88C583D6Q31072762-642C4D44-8FD9-4DDE-BEB8-6EC071B25762Q33649838-AE91E5FF-37B9-4028-A192-FD056AAE5C48Q33785321-95396EBB-5DCD-425C-840D-ACFB9230E6E4Q33863026-AC591104-8CCB-4AE3-888C-E3B75F232618Q34031308-AA0B92F4-8D51-4937-8DA0-E34EED45ED67Q34174032-22A67968-A98D-4C42-876C-77D073D0E52CQ34587184-8F07CC27-CFDB-422E-9D23-4CDBA00F3F2DQ34755910-BADBE846-6EC1-4C29-B88F-ACA0F1F4A19BQ35000687-193A767A-E974-4910-9127-4617C2A51B99Q35024694-CE6FD8F1-3A16-490F-96C2-59E3F49B401FQ35483696-99B9DEC2-D0B5-459D-86B2-87DD6001C47AQ35606725-ECFF11CB-1106-4943-8B47-F0F6365975ACQ35613792-4055F625-3EEA-4E21-BA56-7B95863F3D6FQ35779848-B118AE88-3AA3-4616-8828-80535CC8AD79Q35832053-8144BAD5-5AEF-450A-B81E-870001569BFCQ35926764-DAC5F9BB-C60D-4AE2-BAE0-3654BA22D870Q36231252-46D62202-4551-44FE-8639-F208C88222CBQ36233715-086B8DD4-7D17-4367-8FB6-1D41237B3813Q36316638-215213EE-E231-4580-AAB8-E9DA16269EF0Q36639380-F8A5CCCB-6500-4B0A-8603-9A495629B580Q36698842-0016826F-CCDB-4204-B727-B4C9C42B2477Q37056955-BE2BE05D-6C2A-4D25-BE4E-31E21352E83CQ37825906-5E880840-510A-466D-A03E-B9DC86CB0A9EQ38292349-89AA3141-E619-4F47-AE37-5759AE1EADA2Q38317787-EEA7140B-F900-4713-BECB-618E178AAB07Q39733480-C66CC49B-180A-4E3E-A777-11896C805065Q40489692-81DBF2C5-2F45-4137-9838-DA8A32B21AB5Q40676905-D08A78BD-E8D1-4217-882F-0B9194B86EB7Q41118719-72E408F2-78D3-4D60-8167-514A98F48869Q41841039-8368C820-A903-4195-B6C8-F4E02F62485DQ42007452-E3F7CF2A-6510-4C82-9CF6-F59102CBD7F9Q45764762-035658C8-5AB5-4FF5-B5E4-E6AAE7062B6BQ46830857-48434D33-1974-40E7-82C2-B51E024DEA4E
P2860
Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@ast
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@en
type
label
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@ast
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@en
prefLabel
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@ast
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@en
P2093
P2860
P356
P1476
Identification of an Arg-Gly-A ...... 1 transactivation protein, tat
@en
P2093
P2860
P304
P356
10.1083/JCB.111.3.1275
P407
P577
1990-09-01T00:00:00Z